Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HOME Study: HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device - (HOme Monitoring of the Eye)

NCT01103505 is registered in ClinicalTrials.gov with Notal Vision Ltd. as lead sponsor.

NCT NCT01103505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01103505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HOME Study: HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device - (HOme Monitoring of the Eye)
Lead sponsor
Notal Vision Ltd.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2013
Enrollment
1,520 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration